Myeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test Price 4200 AED
Test Name:
Myeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test
Components:
EDTA Vacutainer (2ml)
Price:
4200.0 AED
Sample Condition:
Bone marrow / Peripheral blood (Transport immediately)
Report Delivery:
5-7 days
Method:
Real Time PCR + Sanger Sequencing
Test type:
Genetics
Doctor: Gynecologist
Test Department:
Pre Test Information
Myeloproliferative Neoplasia (MPN) Panel (BCR QLT,JAK2 PANEL,CALR, MPL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details:
The Myeloproliferative Neoplasia (MPN) Panel is a diagnostic test used to detect genetic mutations associated with myeloproliferative neoplasms, a group of blood disorders characterized by the overproduction of certain types of blood cells.
The panel includes the following genetic tests:
- BCR-ABL1 Quantitative PCR (BCR QLT): This test is used to detect the BCR-ABL1 fusion gene, which is a genetic abnormality commonly found in chronic myeloid leukemia (CML). The presence of this fusion gene helps in the diagnosis and monitoring of CML.
- JAK2 Panel: This panel includes tests for mutations in the JAK2 gene, specifically the V617F mutation. The JAK2 V617F mutation is found in a majority of patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Detection of this mutation is essential for the diagnosis of these MPNs.
- CALR Mutation Analysis: This test is used to detect mutations in the CALR gene, which is also associated with MPNs, particularly essential thrombocythemia and primary myelofibrosis. CALR mutations are mutually exclusive with JAK2 and MPL mutations and are found in a significant proportion of patients with these MPNs.
- MPL Mutation Analysis: This test detects mutations in the MPL gene, which is another gene associated with MPNs, specifically essential thrombocythemia and primary myelofibrosis. MPL mutations are mutually exclusive with JAK2 and CALR mutations and are found in a small subset of patients with these MPNs.
By analyzing these genetic mutations, the MPN panel helps in the diagnosis, risk stratification, and monitoring of patients with myeloproliferative neoplasms.
Test Name | Myeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 4200.0 AED |
Sample Condition | Bone marrow \/ Peripheral blood (Transport immediately) |
Report Delivery | 5-7 days |
Method | Real Time PCR + Sanger Sequencing |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | Myeloproliferative Neoplasia (MPN) Panel (BCR QLT,JAK2 PANEL,CALR, MPL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | The Myeloproliferative Neoplasia (MPN) Panel is a diagnostic test used to detect genetic mutations associated with myeloproliferative neoplasms, a group of blood disorders characterized by the overproduction of certain types of blood cells. The panel includes the following genetic tests: 1. BCR-ABL1 Quantitative PCR (BCR QLT): This test is used to detect the BCR-ABL1 fusion gene, which is a genetic abnormality commonly found in chronic myeloid leukemia (CML). The presence of this fusion gene helps in the diagnosis and monitoring of CML. 2. JAK2 Panel: This panel includes tests for mutations in the JAK2 gene, specifically the V617F mutation. The JAK2 V617F mutation is found in a majority of patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Detection of this mutation is essential for the diagnosis of these MPNs. 3. CALR Mutation Analysis: This test is used to detect mutations in the CALR gene, which is also associated with MPNs, particularly essential thrombocythemia and primary myelofibrosis. CALR mutations are mutually exclusive with JAK2 and MPL mutations and are found in a significant proportion of patients with these MPNs. 4. MPL Mutation Analysis: This test detects mutations in the MPL gene, which is another gene associated with MPNs, specifically essential thrombocythemia and primary myelofibrosis. MPL mutations are mutually exclusive with JAK2 and CALR mutations and are found in a small subset of patients with these MPNs. By analyzing these genetic mutations, the MPN panel helps in the diagnosis, risk stratification, and monitoring of patients with myeloproliferative neoplasms. |